TGFB1 and pulmonary fibrosis: TGF-β and its signaling pathway are known to play a key role in the development of pulmonary fibrosis [32], and treatments aimed at controlling the levels of this cytokine appear to be effective in reducing the fibrotic process, modulating fibroblast activation and, consequently, the progression of the disease [33].